News

“Targets for Tomorrow” Workshop at GRC in Italy July 2013

We invite you to join us for the “Targets for Tomorrow” satellite workshop hosted by the WGND Biology/Targets Subgroup on Monday, July 22, 2013 from 2 p.m. to 4:30 p.m. at the Renaissance Tuscany Il Ciocco Resort, Lucca (Barga), Italy. The workshop is held in conjunction with the Gordon Conference on TB Drug Development (July 21-26). The objectives of the meeting are to:

  • Allow key entities involved strategically in TB drug discovery to present their views of the needs, directions and targets for tomorrow to the research community
  • Discuss the puzzling finding of ‘promiscuous targets’
  • Set a priority list of what constitutes good targets and what does not to develop a universal “go/no go” checklist for targets
“Targets For Tomorrow” Satellite Workshop
AGENDA
Workshop Chair: Thomas Dick
2:00 p.m.-3:15pm: Needs & directions in TB drug discovery–Leader: Petros KarakousisSession Speakers:
  • Barbara Laughon (NIAID/NIH)
  • Ken Duncan (Bill & Melinda Gates Foundation)
  • Anna Upton (TB Alliance)
  • Alfonso Mendoza-Losana (GlaxoSmithKline)
  • Petros Karakousis (Johns Hopkins)
3:15-3:30pm: Break
3:30-4:30pm: ‘Promiscuous targets’–Leader: Tanya ParishDiscussion Topics:
  • What makes a good target—Speaker: Bavesh Kana
  • Results from current target ID efforts– Speaker: Dirk Schnappinger
  • Are promiscuous targets good or bad– Speaker: TBD
  • Best approaches to target-based screening—Speaker: Helena Boshoff

Light refreshments will be served.

If you plan on attending the satellite workshop, please RSVP by e-mailing wgnd@newtbdrugs.org.

More News
22 Jul 2024
The National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) has issued a $30.8 million grant to the Preclinical Design and Clinical Translation of TB Regimens (PreDiCTR) consortium , a new consortium co-led by investigators from Weill Cornell Medicine; the...
27 Jun 2024
On May 17, the World Health Organization (WHO) released its updated  Bacterial Priority Pathogens List (BPPL) 2024 and for the first time in its history it included a drug resistant strain of Mycobacterium tuberculosis. Along with three other new families of antibiotic-resistant bacterial pathogens...
19 Mar 2024
For World TB Day 2024, the WGND is spotlighting a monumental achievement in TB drug research and development: the Global TB Drug Pipeline has never been bigger than it is today. The number of drug candidates being clinically evaluated for use in the treatment of adult pulmonary TB has surpassed...